Robert Zukermann

Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

Piotr Ponikowski, Bridget‐Anne Kirwan, Stefan D. Anker et al. · The Lancet · 2020 · 761 citations · Full text

Medicine, Cardiology, Iron Metabolism Disorders +11

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Return to training in the COVID‐19 era: The physiological effects of face masks during exercise

Danny Epstein, Alexander Korytny, Yoni Isenberg et al. · Scandinavian Journal of Medicine and Science in Sports · 2020 · 245 citations · Full text

Medicine, Health Promotion, Sports Medicine +16

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction

Robert Dragu, Shafik Huri, Robert Zukermann et al. · Atherosclerosis · 2006 · 148 citations

Medicine, Cardiology, Hematology +16